Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-25
2009-06-23
Wilson, James O. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S152000, C546S153000, C546S159000, C514S183000, C514S249000, C514S252100, C514S314000
Reexamination Certificate
active
07550597
ABSTRACT:
This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor tyrosine kinase and/or Lck tyrosine kinase, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
REFERENCES:
patent: 5409930 (1995-04-01), Spada et al.
patent: 5480883 (1996-01-01), Spada et al.
patent: 6846815 (2005-01-01), Myers et al.
Maguire Martin P.
Myers Michael R.
Persons Paul E.
Spada Alfred P.
Aventis Pharmaceuticals Inc.
Synnestvedt & Lechner LLP
Ward Paul V.
Wilson James O.
LandOfFree
Quinoline and quinoxaline compounds which inhibit... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline and quinoxaline compounds which inhibit..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline and quinoxaline compounds which inhibit... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4131074